Home » Stocks » AMRS

Amyris, Inc. (AMRS)

Stock Price: $11.49 USD -0.73 (-5.97%)
Updated May 10, 2021 3:36 PM EDT - Market open
Market Cap 3.53B
Revenue (ttm) 320.87M
Net Income (ttm) -585.80M
Shares Out 267.73M
EPS (ttm) -2.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $11.49
Previous Close $12.22
Change ($) -0.73
Change (%) -5.97%
Day's Open 12.09
Day's Range 11.41 - 12.25
Day's Volume 2,582,883
52-Week Range 1.88 - 23.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 days ago - Zacks Investment Research

EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today an...

4 days ago - PRNewsWire

EMERYVILLE, Calif., May 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier o...

5 days ago - PRNewsWire

Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.

5 days ago - Zacks Investment Research

EMERYVILLE, Calif. and WESTCHESTER, Ill.

Other stocks mentioned: INGR
1 week ago - PRNewsWire

Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.

1 week ago - Zacks Investment Research

Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...

2 weeks ago - PRNewsWire

EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...

2 weeks ago - PRNewsWire

EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

3 weeks ago - PRNewsWire

EMERYVILLE, Calif., April 14, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

3 weeks ago - PRNewsWire

Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.

1 month ago - Schaeffers Research

EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...

1 month ago - PRNewsWire

EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...

1 month ago - PRNewsWire

If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.

1 month ago - GuruFocus

A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...

Other stocks mentioned: DCP, EXPI, FLGT, FUTU, MIK, SI, SPWR
1 month ago - InvestorPlace

EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

1 month ago - PRNewsWire

EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

1 month ago - PRNewsWire

EMERYVILLE, Calif., March 31, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

1 month ago - PRNewsWire

EMERYVILLE, Calif., March 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

1 month ago - PRNewsWire

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft

Other stocks mentioned: ADUS, AMZN, ATEC, MSFT
1 month ago - CNBC

EMERYVILLE, Calif., March 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

1 month ago - PRNewsWire

The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.

1 month ago - Forbes

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.

Other stocks mentioned: LAMR, NLS, UBER, ABBV, ABNB, BA, CLNE ...
1 month ago - Benzinga

EMERYVILLE, Calif., March 10, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...

2 months ago - PRNewsWire

EMERYVILLE, Calif., March 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

2 months ago - PRNewsWire

Shares of Amyris (NASDAQ:AMRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 92.11% year over year to ($0.03), which beat the estimate of ($0.09).

2 months ago - Benzinga

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for March.

Other stocks mentioned: APHA, CRON, EGOV, GRWG, OGI, VFF
2 months ago - Investopedia

Even with the market at historic highs, there are still plenty of young growth stocks that have their whole future ahead of them. The post 7 A-Rated Growth Stocks To Buy For Today And Tomorrow appeared ...

Other stocks mentioned: APPS, GRWG, JMIA, OSTK, SBE, SI
3 months ago - InvestorPlace

These are the marijuana stocks with the best value, fastest growth, and most momentum for February 2021.

Other stocks mentioned: EGOV, GRWG, IIPR
3 months ago - Investopedia

Some of the best cheap stocks for 2021 include chipmakers like UMC stock and pharmaceuticals in the COVID-19 vaccine race such as INO stock. The post 7 Great Cheap Stocks To Buy For Solid Growth In 2021...

Other stocks mentioned: CLNE, GNMK, HIMX, INO, STKL, UMC
3 months ago - InvestorPlace

EMERYVILLE, Calif., Jan. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...

3 months ago - PRNewsWire

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for February.

Other stocks mentioned: APHA, CGC, CRON, EGOV, GRWG, OGI, VFF
3 months ago - Investopedia

Over halfway through the trading day on Wednesday, and the broad markets are making a run into the afternoon.

Other stocks mentioned: TSLA, C, GS, JPM, KDP, MDB, MS ...
4 months ago - 24/7 Wall Street

Looking for penny stocks to buy? Click for seven that are hot right now and should continue to rise in the future.

Other stocks mentioned: CNSP, CYRN, MREO, NGD, RARE, XELA
4 months ago - InvestorPlace

EMERYVILLE, Calif., Dec. 28, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...

4 months ago - PRNewsWire

Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.

4 months ago - Zacks Investment Research

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for January.

Other stocks mentioned: CGC, CRON, EGOV, GRWG, OGI, VFF
4 months ago - Investopedia

Amyris (AMRS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

4 months ago - Zacks Investment Research

EMERYVILLE, Calif., Dec. 21, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...

4 months ago - PRNewsWire

Amyris has multiple major transactions around the corner. The political and market environment favor the company greatly.

4 months ago - Seeking Alpha

EMERYVILLE, Calif., Dec. 3, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a t...

5 months ago - PRNewsWire

These are the marijuana stocks with the best value, fastest growth, and most momentum for December.

Other stocks mentioned: GRWG
5 months ago - Investopedia

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for November.

Other stocks mentioned: APHA, CGC, CRON, EGOV, GRWG, VFF
5 months ago - Investopedia

Amyris, Inc. (AMRS) CEO John Melo on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplie...

6 months ago - PRNewsWire

BENSALEM, Pa.--(BUSINESS WIRE)---- $AMRS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

6 months ago - Business Wire

LOS ANGELES--(BUSINESS WIRE)---- $AMRS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

6 months ago - Business Wire

EMERYVILLE, Calif., Oct. 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplie...

6 months ago - PRNewsWire

SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary n...

6 months ago - PRNewsWire

About AMRS

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Ins... [Read more...]

Industry
Specialty Chemicals
IPO Date
Sep 28, 2010
CEO
John Melo
Employees
595
Stock Exchange
NASDAQ
Ticker Symbol
AMRS
Full Company Profile

Financial Performance

In 2020, Amyris's revenue was $173.14 million, an increase of 13.49% compared to the previous year's $152.56 million. Losses were -$331.04 million, 36.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Amyris stock is "Strong Buy." The 12-month stock price forecast is 26.00, which is an increase of 126.28% from the latest price.

Price Target
$26.00
(126.28% upside)
Analyst Consensus: Strong Buy